FIELD: medicine, therapy. SUBSTANCE: invention relates to treatment of patients with states where bradykinin excess takes part. For this purpose invention proposes to use the group of 2-phenyl-3-aroylbenzothiophenes as antagonists of bradykinin receptors. Method provides inhibition of pathological state associated with bradykinin participation. EFFECT: enhanced effectiveness of method. 3 cl
Authors
Dates
2002-04-10—Published
1995-10-19—Filed